Sigyn Therapeutics Inc (SIGY)
5.25
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Sigyn Therapeutics Max Drawdown (5Y): 99.93% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.93% |
March 31, 2024 | 99.93% |
February 29, 2024 | 99.93% |
January 31, 2024 | 99.93% |
December 31, 2023 | 99.93% |
November 30, 2023 | 99.93% |
October 31, 2023 | 99.93% |
September 30, 2023 | 99.93% |
August 31, 2023 | 99.93% |
July 31, 2023 | 99.93% |
June 30, 2023 | 99.93% |
May 31, 2023 | 99.93% |
April 30, 2023 | 99.93% |
March 31, 2023 | 99.93% |
February 28, 2023 | 99.93% |
January 31, 2023 | 99.93% |
December 31, 2022 | 99.93% |
November 30, 2022 | 99.93% |
October 31, 2022 | 99.93% |
September 30, 2022 | 99.93% |
August 31, 2022 | 99.93% |
July 31, 2022 | 99.93% |
June 30, 2022 | 99.93% |
May 31, 2022 | 99.93% |
April 30, 2022 | 99.93% |
Date | Value |
---|---|
March 31, 2022 | 99.93% |
February 28, 2022 | 99.93% |
January 31, 2022 | 99.93% |
December 31, 2021 | 99.93% |
November 30, 2021 | 99.93% |
October 31, 2021 | 99.93% |
September 30, 2021 | 99.99% |
August 31, 2021 | 99.99% |
July 31, 2021 | 99.99% |
June 30, 2021 | 99.99% |
May 31, 2021 | 99.99% |
April 30, 2021 | 99.99% |
March 31, 2021 | 99.99% |
February 28, 2021 | 99.99% |
January 31, 2021 | 99.99% |
December 31, 2020 | 99.99% |
November 30, 2020 | 99.99% |
October 31, 2020 | 99.99% |
September 30, 2020 | 99.99% |
August 31, 2020 | 99.99% |
July 31, 2020 | 99.99% |
June 30, 2020 | 99.99% |
May 31, 2020 | 99.99% |
April 30, 2020 | 99.99% |
March 31, 2020 | 99.99% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.93%
Minimum
Oct 2021
99.99%
Maximum
May 2019
99.96%
Average
99.93%
Median
Oct 2021
Max Drawdown (5Y) Benchmarks
CEL-SCI Corp | 96.13% |
AIM ImmunoTech Inc | 99.76% |
IGC Pharma Inc | 97.77% |
NovaBay Pharmaceuticals Inc | 99.91% |
Protalix BioTherapeutics Inc | 94.35% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -27.08 |
Beta (5Y) | -1.665 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 367.8% |
Historical Sharpe Ratio (5Y) | -0.1241 |
Historical Sortino (5Y) | -0.7944 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 46.15% |